Global Medical Imaging Lens Market Overview:
Medical imaging is the method and procedure of imaging the interior of a body for clinical diagnosis and medical intervention, as well as visual representation of the function of certain organs or tissues. Medical imaging aims to expose secret internal structures under the skin and bones, as well as diagnose and treat disease. Medical imaging also creates a database of normal anatomy and physiology, allowing anomalies to be detected. As the need for effective solutions and an emphasis on early disease detection grows, the healthcare sector is seeing a huge amount of investment in this technology. Furthermore, as the prevalence of neurological and ophthalmological disorders rises in the population, demand for imaging diagnosis may rise, propelling the market forward. Diagnostic imaging is the process of obtaining visual images of the interior of a body for diagnostic and therapeutic purposes using various imaging modalities. The increasing incidence of chronic and acute diseases such as cancer, cardiovascular diseases, and orthopedic disorders in the general population is presenting a large patient pool undergoing diagnostic imaging.
As per latest study released by AMA Research, the Global Medical Imaging Lens market is expected to see growth rate of 11.0%Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Augmented Reality (AR) in Medical Imaging lens market
Market Growth Drivers:
Increasing Incidents of Cardiovascular and Neurological Disorders and Increasing Demand for Early-Stage Diagnosis
Challenges:
Frequent Product Recalls and Stringent Regulatory Factors
Restraints:
High Cost of these Products as Well as High Cost of Treatments and Lack of skilled operators
Opportunities:
Increased Investment in Research and Development and Growth in Untapped Markets
Competitive Landscape:
Key players are adopting numerous strategies to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnerships to adopt certain technologies, and acquiring small players to finish the competition in the future. As well as investing money in the R&D sector to make technical upgrades to the product.
Some of the key players profiled in the report are Carl Zeiss Meditec AG (Germany), Abbott (United States), Topcon Corporation (Japan), Canon Inc. (Japan), PerkinElmer, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Heidelberg Engineering (United States), Leica Microsystems (Germany), Headwall Photonics, Inc. (United States) and Optovue Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like DermaLumics (Spain) and Cylite Pty Ltd. (Australia). Analyst at AMA Research see United States Players to retain maximum share of Global Medical Imaging Lens market by 2030. Considering Market by Imaging Technique, the sub-segment i.e. Optical Coherence Tomography (OCT) will boost the Medical Imaging Lens market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Medical Imaging Lens market. Considering Market by Therapeutic Area, the sub-segment i.e. Ophthalmology will boost the Medical Imaging Lens market.
Latest Market Insights:
December 2020 – ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image processing, and analysis software for research microscopy.
May 2020 – Canon Medical Partners with Surfacide to Provide Rapid Decontamination Solution for Imaging Systems.
Class II devices require Premarket Notification 510(k); and most Class III devices require Premarket Approval. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act)
What Can be Explored with the Medical Imaging Lens Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Medical Imaging Lens Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Medical Imaging Lens
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Medical Imaging Lens market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Medical Imaging Lens market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Medical Imaging Lens, Suppliers of Medical Imaging Lens, Wholesalers, Distributors and Retailers of Medical Imaging Lens, Healthcare Industry, Governmental Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.